ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Status:
Not yet recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to test if mutations (changes in DNA) in exons (segment of
DNA or RNA containing information that has the instructions for making proteins) in the KIT
gene can be used to predict the body's response to standard of care treatment.